Literature DB >> 8219965

Drug treatment during Ramadan. Don't be complacent about diabetes.

A E Gold, K M MacLeod, B M Frier.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8219965      PMCID： PMC1696447          DOI： 10.1136/bmj.307.6907.800-c

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  5 in total

1.  Long-term comparative trial of glibenclamide and chlorpropamide in diet-failed, maturity-onset diabetics.

Authors:  B F Clarke; I W Campbell
Journal:  Lancet       Date:  1975-02-01       Impact factor: 79.321

2.  Symptomatic hypoglycemia in NIDDM patients treated with oral hypoglycemic agents.

Authors:  A M Jennings; R M Wilson; J D Ward
Journal:  Diabetes Care       Date:  1989-03       Impact factor: 19.112

3.  The relationship between symptomatic and biochemical hypoglycaemia in insulin-dependent diabetic patients.

Authors:  S Pramming; B Thorsteinsson; I Bendtson; C Binder
Journal:  J Intern Med       Date:  1990-12       Impact factor: 8.989

4.  Muslims with non-insulin dependent diabetes fasting during Ramadan: treatment with glibenclamide.

Authors:  J Belkhadir; H el Ghomari; N Klöcker; A Mikou; M Nasciri; M Sabri
Journal:  BMJ       Date:  1993-07-31

5.  Symptomatic hypoglycaemia in 411 type 1 diabetic patients.

Authors:  S Pramming; B Thorsteinsson; I Bendtson; C Binder
Journal:  Diabet Med       Date:  1991-04       Impact factor: 4.359
  5 in total
  1 in total

1.  Incidence of hypoglycaemia in patients with type-2 diabetes taking multiple glucose lowering therapies during Ramadan: the PROFAST Ramadan Study.

Authors:  Tarik Elhadd; Zeinab Dabbous; Mohammed Bashir; Abdulnasir Elzouki; Wissam Ghadban; Khaled Baagar; Silas Benjamin; Mohamed Hassanien; Abazar A M Saeed; Khaled Dukhan; Rayaz A Malik; Abdul-Badie Abou-Samra
Journal:  J Diabetes Metab Disord       Date:  2018-11-19
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.